$ADAP Adaptimmune Therapeutics PLC Insider Trading
Get free email notifications about insider trading in Adaptimmune Therapeutics PLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Adaptimmune Therapeutics PLC. Insider overview, share value development, latest insider transactions and email notifications about new events in Adaptimmune Therapeutics PLC for free.
CIK Number: 0001621227
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: ADAP
Company Address: 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE OX14 4RX
Phone number: 44 1235 430000
Former name: Adaptimmune Ltd, date of change: 2014-10-01
Market Capitalization: $321.36M
Prev close: $4.53
Average Daily Volume: 132,921
Days Low: $4.41
Year Low: $3.76
Year High: $11.59
Adaptimmune Therapeutics PLC Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 28 2021 | ADAP | Adaptimmune Therap ... | Rawcliffe Adrian | Chief Executive Off ... | Sell | S | 4.37 | 2,794 | 12,210 | 3,058 | 5.9 K to 3.1 K (-47.74 %) |
Mar 03 2021 | ADAP | Adaptimmune Therap ... | TAYTON-MARTIN HELEN KATRINA | Chief Business Offi ... | Buy | M | 0.16 | 1,785,000 | 280,245 | 1,800,000 | 15 K to 1.8 M (+11,900.00 %) |
Jan 19 2021 | ADAP | Adaptimmune Therap ... | Norry Elliot | Chief Medical Offic ... | Sell | S | 5.67 | 2,111 | 11,968 | 3,539 | 5.7 K to 3.5 K (-37.36 %) |
Jan 19 2021 | ADAP | Adaptimmune Therap ... | Lunger John | Chief Patient Suppl ... | Sell | S | 5.67 | 4,358 | 24,708 | 7,346 | 11.7 K to 7.3 K (-37.24 %) |
Jan 19 2021 | ADAP | Adaptimmune Therap ... | Rawcliffe Adrian | Chief Executive Off ... | Sell | S | 5.67 | 9,879 | 56,009 | 13,529 | 23.4 K to 13.5 K (-42.20 %) |
Jan 12 2021 | ADAP | Adaptimmune Therap ... | Bertrand William C JR | Chief Operating Off ... | Sell | S | 6.15 | 2,234 | 13,744 | 3,768 | 6 K to 3.8 K (-37.22 %) |
Jan 12 2021 | ADAP | Adaptimmune Therap ... | Lunger John | Chief Patient Suppl ... | Sell | S | 6.15 | 1,058 | 6,509 | 1,767 | 2.8 K to 1.8 K (-37.45 %) |
Jan 12 2021 | ADAP | Adaptimmune Therap ... | Norry Elliot | Chief Medical Offic ... | Sell | S | 6.15 | 841 | 5,174 | 1,396 | 2.2 K to 1.4 K (-37.59 %) |
Jan 12 2021 | ADAP | Adaptimmune Therap ... | Rawcliffe Adrian | Chief Executive Off ... | Sell | S | 6.15 | 2,707 | 16,654 | 3,695 | 6.4 K to 3.7 K (-42.28 %) |
Jan 11 2021 | ADAP | Adaptimmune Therap ... | Wood Gavin | Chief Financial Off ... | Option Exercise | A | 0.00 | 242,712 | 340 | 242,712 | |
Jan 11 2021 | ADAP | Adaptimmune Therap ... | Wood Gavin | Chief Financial Off ... | Option Exercise | A | 1.03 | 1,086,816 | 1,119,420 | 1,086,816 | |
Jan 11 2021 | ADAP | Adaptimmune Therap ... | Norry Elliot | Chief Medical Offic ... | Option Exercise | A | 0.00 | 242,712 | 340 | 242,712 | |
Jan 11 2021 | ADAP | Adaptimmune Therap ... | Norry Elliot | Chief Medical Offic ... | Option Exercise | A | 1.03 | 1,086,816 | 1,119,420 | 1,086,816 | |
Jan 11 2021 | ADAP | Adaptimmune Therap ... | Rawcliffe Adrian | Chief Executive Off ... | Option Exercise | A | 0.00 | 728,160 | 1,019 | 728,160 | |
Jan 11 2021 | ADAP | Adaptimmune Therap ... | Rawcliffe Adrian | Chief Executive Off ... | Option Exercise | A | 1.03 | 3,260,400 | 3,358,212 | 3,260,400 |